← back to search

Jihong Han

Shenyang Pharmaceutical University · CN
Area of research
Molecular Biology · Surgery
Research interest
Research interests include Peroxisome Proliferator-Activated Receptors, Cholesterol and Lipid Metabolism, Cancer, Lipids, and Metabolism, and Adipokines, Inflammation, and Metabolic Diseases.
h-index
42
citations
6,861
works
155
NIH funding
primary concept
email

Recent publications

Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6/STAT3 signaling pathway and the interplay between VSMCs and ECs
Acta Pharmacologica Sinica 2023cited by 30position: middledoi
MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis
Bioengineered 2022cited by 4position: middledoi
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
Pharmacological Reviews 2021cited by 1,058position: middledoi
NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity
Journal of Biological Chemistry 2021cited by 21position: middledoi
Rosiglitazone alleviates intrahepatic cholestasis induced by α‐naphthylisothiocyanate in mice: The role of circulating 15‐deoxy‐Δ<sup>12,14</sup>‐PGJ<sub>2</sub> and Nogo
British Journal of Pharmacology 2019cited by 31position: middledoi
25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism
Journal of Lipid Research 2018cited by 88position: middledoi
Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen
Journal of Biological Chemistry 2016cited by 73position: middledoi
Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice
Arteriosclerosis Thrombosis and Vascular Biology 2015cited by 109position: lastdoi
Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model
Biomaterials 2012cited by 283position: middledoi
Peroxisome Proliferator-activated Receptor γ Activation by Ligands and Dephosphorylation Induces Proprotein Convertase Subtilisin Kexin Type 9 and Low Density Lipoprotein Receptor Expression
Journal of Biological Chemistry 2012cited by 86position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Yajun Duan · University of Science and Technology of China8 papers (2012–2023)Xiaoxiao Yang · Hefei University of Technology8 papers (2012–2023)Qing Miao · Long Island University5 papers (2015–2023)David P. Hajjar · Matrix Research (United States)4 papers (2012–2019)Wenquan Hu · Xihua University4 papers (2012–2021)Meixiu Jiang · Nanchang University3 papers (2016–2023)Xiaoju Li · Shihezi University3 papers (2012–2019)Xingzhe Ma · Houston Methodist2 papers (2015–2018)Suowen Xu · University of Science and Technology of China2 papers (2021–2023)Mengmeng Zhu · University of Florida2 papers (2022–2023)Lei Sun · State Key Laboratory of Food Science and Technology2 papers (2015–2018)Shuang Zhang · Soochow University2 papers (2016–2021)Wei Zhuo · Tsinghua University2 papers (2018–2019)Xiaoju Li · Shandong University2 papers (2016–2021)Miao Yu · Beijing Proteome Research Center2 papers (2016–2019)Deling Kong · Sun Yat-sen University2 papers (2012–2012)Chuanrui Ma · Medical College of Wisconsin2 papers (2018–2019)Jianping Weng · University of Science and Technology of China1 papers (2021–2021)Ian C. Harding · Northeastern University1 papers (2021–2021)Lin Liu · Shandong University1 papers (2012–2012)